Additionally, cholestasis in PBC patients raises levels of lithocholic acid and bilirubin, which can adversely affect osteoblasts and osteoblast-like cells, such as SAOS-2, through bile acid transport proteins like bile acid transport protein (BSEP) and multidrug resistance-associated protein (MRP). This evidence concerns the gene ABCC3 and cholestasis.